{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:49:45Z","timestamp":1775195385198,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaad.2020.04.172","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T03:56:33Z","timestamp":1588823793000},"page":"497-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis"],"prefix":"10.1016","volume":"84","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Geizhals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2020.04.172_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","article-title":"Onychomycosis: treatment and prevention of recurrence","volume":"80","author":"Lipner","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.172_bib2","doi-asserted-by":"crossref","unstructured":"Gupta, A.K., Stec N, Summerbell RC, et\u00a0al., Onychomycosis: a review [e-pub ahead of print]. J Eur Acad Dermatol Venereol https:\/\/doi.org\/10.1111\/jdv.16394, Accessed June 8, 2020.","DOI":"10.1111\/jdv.16394"},{"issue":"12","key":"10.1016\/j.jaad.2020.04.172_bib3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jamadermatol.2018.3578","article-title":"Utility of laboratory test result monitoring in patients taking oral terbinafine or griseofulvin for dermatophyte infections","volume":"154","author":"Stolmeier","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.04.172_bib4","first-page":"117","article-title":"The de ritis ratio: the test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin Biochem Rev"},{"issue":"3","key":"10.1016\/j.jaad.2020.04.172_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamadermatol.2015.4203","article-title":"Reevaluating the need for laboratory testing in the treatment of onychomycosis: safety and cost-effectiveness considerations","volume":"152","author":"Kanzler","year":"2016","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222030832X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222030832X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:57:52Z","timestamp":1759273072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222030832X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S019096222030832X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.172","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}